Continuing on the Pathway to Success
Numinus participates in COMP360's landmark Phase III trial. It has been announced that Numinus' Cedar Clinical Research (CCR) is a participant in COMPASS Pathways' (CMPS) landmark COMP360 Phase III program investigating psilocybin-assisted therapy in treatment-resistant depression (TRD). The COMP360 Phase III studies, the first ever Phase III program of psilocybin therapy and the largest clinical study of a psychedelic compound, comprises two pivotal trials with an integrated long-term outcomes component...CCR's participation means that Numinus has now collaborated in the two most advanced psychedelic-assisted therapy programs. Numinus' Vancouver research facility was one of the sites involved in MAPS' successful Phase III trials of its MDMA-assisted therapy for PTSD...Rojo Resources is an exploration stage company. Co. is engaged in the mineral exploration activities in Canada, the United States and Mongolia.
Water Tower Research is built on the foundation of democratizing information flow. We bridge the growing information gap between companies and investors through our investor engagement strategies and open-access research platform.
Our research analysts are Wall Street veterans with the experience and knowledge to work with companies and investors in tandem. We provide access to the information and content that anchors the due diligence process for both professional money managers and individual investors. We leverage traditional research distribution channels and the best of modern digital strategies and tactics to amplify this information flow globally to engage all categories of investors and stakeholders.
Information flow is the foundation for creating investor awareness, knowledge, and engagement. Our mission is to help companies and investors have the tools they need and achieve their goals.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.